Cardiovascular Pharmacology: Endothelial Control
- Paul Vanhoutte
Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions
Included in series
Advances in Pharmacology
Advances in Pharmacology
Hardbound, 336 Pages
Published: December 2010
Imprint: Academic Press
ISBN: 978-0-12-385061-4
Contents
- The Cardiovascular Physiology and Pharmacology of Endothelin-1 Eric Thorin and Martine Clozel
- Vascular Pharmacology of Epoxyeicosarienoic Acids Sandra L. Pfister, Kathryn M. Gauthier, and William B. Campbell
- Prostaglandins in Action: Indispensable Roles of Cyclooxygenase-1 and 2 in Endothelium-dependent Contractions Siu Ling Wong, Wing Tak Wong, Xiao Yu Tian, Chi-Wai Lau, and Yu Huang
- TP Receptors and Oxidative Stress: Hand in Hand from Endothelial Dysfunction to Atherosclerosis Michel Félétou, Richard A. Cohen, Paul M. Vanhoutte and Tony J. Verbeuren
- Regulation of Endothelial Cell Tetrahydrobiopterin: Pathophysiological and Therapeutic Implications Li Li, Wei Chen, and David G. Harrison
- Polyphenol-Induced Endothelium-Dependent Relaxations: Role of NO and EDHF Valerie B. Schini-Kerth, Cyril Auger, Nelly Etienne-Selloum, and Thierry Chataigneau
- Organic Nitrates and Nitrate Tolerance - State of the Art and Future Developments Andreas Daiber and Tommaso Gori
- Vascular Actions of Adipokines: Molecular Mechanism and Therapeutic Intervention Aimin Xu, Yu Wang, Karen Lam, and Paul M. Vanhoutte
- Cardiovascular Effects of Erythropoietin: An Update
